How to support target identification and eliminate dead-end candidates
How to understand the range of biomarker candidates
How to create sophisticated animal models of human disease to develop biomarkers for proof-of pharmacology
How to facilitate clinical trial stratification and employ early surrogate end points of efficacy
How to define the correlation between biomarker and disease/therapeutic intervention
How to develop fit-for-purpose biomarker assays
How to show the clinical utility of biomarkers to improve diagnosis and make informed decision making
You’ll come away with the knowledge to create an optimum biomarker strategy and be able to move towards personalised therapeutics.
Biomarkers World Europe focus:
Understand the role of public-private platform and open innovation between academia and competitors
Learn how to validate companion diagnostics with well established performance characteristics and clinical significance in the present regulatory framework
Develop prognostic and predictive diagnostic technologies and create a personalised medicine strategy
Debate the issues of validating biomarker assay performance, specimen standardisation and quality controlled data collection
Hear practical solutions to creating an optimum biomarker strategy
